Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-14Clinical Trial Update: Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep
A clinical trial evaluating a digital health intervention for adolescent insomnia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-03Clinical Trial Update: Mindfulness in Medical Training [NA]
A clinical trial on mindfulness in medical training focusing on burnout, anxiety, and sleep has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-01Clinical Trial Update: Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients [Phase 4]
Phase 4 trial evaluating suvorexant (Belsomra) to prevent delirium in hospitalized cancer patients with insomnia has been withdrawn. Sponsor…
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: New Mothers Alpha-Stim [NA]
A clinical trial (NCT04770181) evaluating New Mothers Alpha-Stim for anxiety, depression, insomnia, and sleep quality has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-12Clinical Trial Update: CBT-I Chatbot for Youth [NA]
A clinical trial evaluating a CBT-I chatbot for insomnia in youth has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-09-20Clinical Trial Update: Effectiveness of Cognitive Behavioral Therapy for Insomnia in Young Adults With Chronic Pain [NA]
This clinical trial evaluating cognitive behavioral therapy for insomnia in young adults with chronic pain has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-05Clinical Trial Update: NiteCAPP_HELPS_WD: Improving Sleep and Reducing Opioid Use in Chronic Pain Patients [NA]
The NiteCAPP_HELPS_WD trial assessing sleep improvement and opioid-use reduction in chronic pain patients with chronic insomnia has been wit…
-
CLINICAL_TRIALS withdrawal · 2023-03-24Clinical Trial Update: Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept [Phase 4]
A Phase 4 trial of pimavanserin for insomnia in veterans with PTSD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-04-09Clinical Trial Update: Ramelteon for Complex Insomnia in Veterans With PTSD [Phase 4]
Phase 4 trial of ramelteon for complex insomnia in veterans with PTSD was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-21Clinical Trial Update: Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia [Phase 4]
A Phase 4 trial of suvorexant (Belsomra) for bipolar depression with insomnia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-05-10Clinical Trial Update: Comparison Between Multiple Wrist-worn Actigraphy Devices and Polysomnography [NA]
A clinical trial comparing wrist-worn actigraphy devices with polysomnography for insomnia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Mainstream Sleep Tracking Devices vs Polysomnography [NA]
A clinical trial comparing mainstream sleep tracking devices to polysomnography was withdrawn, involving obstructive sleep apnea, insomnia, …
-
CLINICAL_TRIALS withdrawal · 2017-04-26Clinical Trial Update: The Efficacy of CALPXT96™in Improving Sleep Quality in Patients With Chronic Non-cancer Pain [Phase 3]
A Phase 3 trial evaluating CALPXT96 for improving sleep quality in patients with chronic non-cancer pain has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-07-19Clinical Trial Update: Eval EarlySense Bet Lowenstein Sleeplab
A clinical trial sponsored by EarlySense Ltd. investigating sleep-related conditions (including obesity and various sleep apnea syndromes) h…
-
CLINICAL_TRIALS withdrawal · 2015-09-25Clinical Trial Update: Investigating Affective Mechanisms of Behavioral Sleep Treatment [NA]
The NCT02051543 study on affective mechanisms of behavioral sleep treatment for insomnia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-12Clinical Trial Update: An Exploratory Study of NBI-34060 Capsules and Next Day Functioning [Phase 3]
A Phase 3 exploratory trial of NBI-34060 for insomnia has been withdrawn. No results are provided.
-
CLINICAL_TRIALS withdrawal · 2015-04-17Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population [Phase 1]
Phase 1 pharmacokinetic study of SB-649868 in elderly and female participants for insomnia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-10Clinical Trial Update: To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures [Phase 4]
A Phase 4 clinical trial evaluating the effect of perampanel on sleep in individuals with insomnia and partial-onset epilepsy has been withd…
-
CLINICAL_TRIALS withdrawal · 2015-01-14Clinical Trial Update: An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007) [Phase 3]
A Phase 3 clinical trial studying an investigational drug for insomnia in healthy adult volunteers was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: Insomnia in Patients Undergoing Chemotherapy and Radiation Therapy for Head and Neck Cancer
A Vanderbilt University-led clinical trial investigating insomnia in patients with head and neck cancer undergoing chemotherapy and radiatio…
-
CLINICAL_TRIALS withdrawal · 2013-05-17Clinical Trial Update: Evaluating an Internet-based Intervention for Insomnia in Breast Cancer Survivors [NA]
A clinical trial evaluating an internet-based intervention for insomnia in breast cancer survivors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-11-22Clinical Trial Update: Metacognitive Therapy for Comorbid Insomnia [NA]
The clinical trial evaluating metacognitive therapy for secondary insomnia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-07Clinical Trial Update: Xyrem for Treatment Refractory Insomnia Due to PTSD [Phase 2]
A Phase 2 trial evaluating Xyrem (sodium oxybate) for treatment-refractory insomnia associated with post-traumatic stress disorder has been …
-
CLINICAL_TRIALS withdrawal · 2009-02-12Clinical Trial Update: A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia [Phase 2]
Pfizer's Phase 2 dose-ranging trial of PD 0200390 in elderly subjects with primary insomnia has been withdrawn.